Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guardian Pharmatama is an Indonesian pharmaceutical company focused on manufacturing and commercializing prescription medicines, branded generics, generics, over-the-counter products, vitamins, and supplements. The company appears to operate primarily as a commercial-stage drug manufacturer rather than a clinical-stage biotech developer. Public sources indicate it offers products across categories such as antibiotics, antifungals, antiallergy medicines, respiratory products, dermatology products, and nutritional supplements. It also appears to provide toll manufacturing services and manufactures tablet and liquid dosage forms in compliance with Indonesian GMP standards. The company has been active in the Indonesian market since 1993 and is positioned as a domestic pharma manufacturer serving local demand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guardian Pharmatama.